Development of a novel site-specific mutagenesis assay using MALDI-ToF MS (SSMA-MS).
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsMcLuckie, Keith I.E.
Lamb, John H.
Sandhu, Jatinderpal K.
Pearson, Helen L.
Farmer, Peter B.
Jones, Donald J.L.
MetadataShow full item record
AbstractWe have developed and validated a novel site-specific mutagenesis assay, termed SSMA-MS, which incorporates MALDI-ToF mass spectrometry (MALDI-MS) analysis as a means of determining the mutations induced by a single DNA adduct. The assay involves ligating an adducted deoxyoligonucleotide into supF containing pSP189 plasmid. The plasmid is transfected into human Ad293 kidney cells allowing replication and therefore repair or a mutagenic event to occur. Escherichia coli indicator bacteria are transformed with recovered plasmid and plasmids containing the insert are identified colormetrically, as they behave as frameshift mutations. The plasmid is then amplified and digested using a restriction cocktail of Mbo11 and Mnl1 to yield 12 bp deoxyoligonucleotides, which are characterized by MALDI-MS. MALDI-MS takes advantage of the difference in molecular weight between bases to identify any induced mutations. This analysis method therefore provides qualitative and quantitative information regarding the type and frequency of mutations induced. This assay was developed and validated using an O(6)-methyl-2'-deoxyguanosine adduct, which induced the expected GC-->AT substitutions, when replicated in human or bacterial cells. This approach can be applied to the study of any DNA adduct in any biologically relevant gene sequence (e.g. p53) in human cells and would be particularly amenable to high-throughput analysis.
CitationNucleic Acids Res. 2006, 34 (22):e150
JournalNucleic Acids Research
SponsorsThis work was supported by the Medical Research Council, UK (G0100873). The authors of this paper are partners of ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: ‘Food Quality and Safety’ (Contract No 513943). Funding to pay the Open Access publication charges for this article was provided by the MRC.
- Targeted A --> T and G --> T mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz[a,j]anthracene in M13mp7L2.
- Authors: Min Z, Gill RD, Cortez C, Harvey RG, Loechler EL, DiGiovanni J
- Issue date: 1996 Apr 2
- Mutagenic potential of stereoisomeric bay region (+)- and (-)-cis-anti-benzo[a]pyrene diol epoxide-N2-2'-deoxyguanosine adducts in Escherichia coli and simian kidney cells.
- Authors: Fernandes A, Liu T, Amin S, Geacintov NE, Grollman AP, Moriya M
- Issue date: 1998 Jul 14
- Translesion synthesis of 7,8-dihydro-8-oxo-2'-deoxyguanosine by DNA polymerase eta in vivo.
- Authors: Lee DH, Pfeifer GP
- Issue date: 2008 May 10
- Replication of N2-ethyldeoxyguanosine DNA adducts in the human embryonic kidney cell line 293.
- Authors: Upton DC, Wang X, Blans P, Perrino FW, Fishbein JC, Akman SA
- Issue date: 2006 Jul
- Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
- Authors: McLuckie KI, Crookston RJ, Gaskell M, Farmer PB, Routledge MN, Martin EA, Brown K
- Issue date: 2005 Jun 7